Journey Medical Corporation Common Stock (DERM)

About DERM

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodu…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

58

Website

journeymedicalcorp.com

Fundamentals

1-day range

$6.4$6.77

Market cap

$179.80M

P/E (trailing)

—

P/E (forward)

-107.17

EPS (trailing)

$-0.37

Dividend yield

—

Beta

1.08

Avg. volume

270.4K

Forecasts

4 analyst ratings

Journey Medical Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• DERM

  Journey Medical Corporation Common Stock

  $7.47

  ▼ 0.80%
  Market cap $179.80MP/E —
  $4.31$9.56
• CRBP

  Corbus Pharmaceuticals Holdings Inc. Common Stock

  $10.92

  ▼ 1.93%
  Market cap $180.46MP/E —
  $7.12$20.56
• LFCR

  Lifecore Biomedical Inc. Common Stock

  $4.58

  ▲ 0.88%
  Market cap $181.55MP/E —
  $3.63$8.98
• KRRO

  Korro Bio Inc. Common Stock

  $12.94

  ▼ 2.41%
  Market cap $174.80MP/E —
  $5.2$55.89
• TNXP

  Tonix Pharmaceuticals Holding Corp. Common Stock

  $13.59

  ▲ 0.18%
  Market cap $185.71MP/E —
  $9.4$33.22
• ARCT

  Arcturus Therapeutics Holdings Inc. Common Stock

  $15.19

  ▼ 6.06%
  Market cap $172.81MP/E —
  $5.5$24.17
• OKUR

  OnKure Therapeutics Inc. Class A Common Stock

  $3.78

  ▼ 1.31%
  Market cap $168.06MP/E —
  $2.23$5.38

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction
  SeekingAlpha · 8/19/2026
• B. Riley Securities Reiterates Buy on Journey Medical, Raises Price Target to $15
  Benzinga · 8/13/2026
• 12 Health Care Stocks Moving In Thursday's Pre-Market Session
  Benzinga · 8/13/2026
• Journey Medical Corporation (DERM) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/12/2026
• Journey Medical Q2 EPS $(0.01) Beats $(0.02) Estimate, Sales $17.839M Miss $18.366M Estimate
  Benzinga · 8/12/2026

• Justin Adam Smith · July 1, 2026 · Grant

  50.0K
• Miranda Jayne Toledano · July 1, 2026 · Grant

  50.0K
• Neil Herskowitz · July 1, 2026 · Grant

  50.0K
• Justin Adam Smith · June 25, 2026 · Grant

  10.0K
• Lindsay A. Rosenwald, MD · June 25, 2026 · Grant

  10.0K
• Michael Cooper Pearce · June 25, 2026 · Grant

  10.0K
• Neil Herskowitz · June 25, 2026 · Grant

  10.0K
• Ramsey Alloush · April 22, 2026 · Grant

  62.8K
• Ramsey Alloush · April 22, 2026 · Grant

  46.9K
• Joseph Benesch · April 22, 2026 · Grant

  41.9K
• Joseph Benesch · April 22, 2026 · Grant

  28.9K
• Claude Maraoui · April 22, 2026 · Grant

  82.9K
• Claude Maraoui · April 22, 2026 · Grant

  49.3K

Institutional Ownership

March 31, 2026

Total shares held

11.53M

Total value held

$54.02M

Institutional holders

67